美股新聞 標題聯播 · 近 24 小時 337 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · SPRY近 30 天 2 則 · 第 1 / 1 頁
- ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
- ARS Pharma (SPRY) Cuts Spending As It Chases Neffy Market Share
- Can ARS Pharmaceuticals, Inc. (SPRY) Climb 297.02% to Reach the Level Wall Street Analysts Expect?
- ARS Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
- ARS Pharmaceuticals Inc (SPRY) (Q2 2026) Earnings Call Highlights: Market Share Doubles to 5% ...
- ARS Pharmaceuticals Q2 Earnings Call Highlights
- ARS Pharmaceuticals, Inc. (SPRY) Reports Q2 Loss, Tops Revenue Estimates
- ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
- Cronos Group (CRON) Surpasses Q2 Earnings and Revenue Estimates
- ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
- ARS Pharmaceuticals (SPRY) Appoints Donn Casale As The New CEO
- Strength Seen in CRINETICS PHARM (CRNX): Can Its 98.7% Jump Turn into More Strength?
- ARS Pharmaceuticals Announces CEO Succession
- ARS Pharmaceuticals (SPRY) Is Down 11.5% After Losing Spots in Key Russell 2000 Defensive Indices
- Micron Sparks Fresh AI Stock Rally
- SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today
- SPRY Stock Tanks Over 23% After-Hours — ARS Pharmaceuticals Reports No New Major Insurance Wins For Neffy
- ARS Pharmaceuticals Provides Commercial and Financial Updates
- How The Evolving Story For ARS Pharmaceuticals (SPRY) Could Shape Future Valuation
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。